These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17903145)

  • 1. Nucleic acids amplification technique (NAT) screening for parvovirus B19: the first Italian routine experience.
    Gessoni G; Barin P; Marchiori G
    Transfus Med; 2007 Oct; 17(5):417-9. PubMed ID: 17903145
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma.
    Baylis SA; Shah N; Minor PD
    J Virol Methods; 2004 Oct; 121(1):7-16. PubMed ID: 15350727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of parvovirus B19 infection in children with malignant or hematological disorders.
    Gustafsson I; Kaldensjö T; Lindblom A; Norbeck O; Henter JI; Tolfvenstam T; Broliden K
    Clin Infect Dis; 2010 May; 50(10):1426-7. PubMed ID: 20397933
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009.
    Kooistra K; Mesman HJ; de Waal M; Koppelman MH; Zaaijer HL
    Vox Sang; 2011 Apr; 100(3):261-6. PubMed ID: 20946549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence and significance of parvovirus B19 in blood and blood products.
    Siegl G; Cassinotti P
    Biologicals; 1998 Jun; 26(2):89-94. PubMed ID: 9811511
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of Parvovirus B19 and Hepatitis A virus in Portuguese blood donors.
    Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Ferreira M; Araújo F
    Transfus Apher Sci; 2005 Nov; 33(3):305-9. PubMed ID: 16203176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza B pneumonia with Staphylococcus aureus superinfection associated with parvovirus B19 and concomitant agranulocytosis.
    Krell S; Adams I; Arnold U; Kalinski T; Aumann V; König W; König B
    Infection; 2003 Oct; 31(5):353-8. PubMed ID: 14556063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serologic and molecular detection of human Parvovirus B19 infection.
    Peterlana D; Puccetti A; Corrocher R; Lunardi C
    Clin Chim Acta; 2006 Oct; 372(1-2):14-23. PubMed ID: 16765338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.
    Koppelman MH; Rood IG; Fryer JF; Baylis SA; Cuypers HT
    Vox Sang; 2007 Oct; 93(3):208-15. PubMed ID: 17845257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety of blood products and B19 parvovirus].
    Lefrère JJ; Maniez-Montreuil M; Morel P; Defer C; Laperche S
    Transfus Clin Biol; 2006 Oct; 13(4):235-41. PubMed ID: 16822687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for parvovirus B19 antigen through chemiluminescent enzyme immunoassay is equivalent to B19 nucleic acid amplification test-based screening of pooled plasma.
    Ikegawa M; Ohashi S; Minagi T; Okamoto H; Yunoki M
    Transfusion; 2021 Aug; 61(8):2240-2244. PubMed ID: 34056747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologic manifestations and diagnosis of parvovirus B19 infections.
    Young NS
    Clin Adv Hematol Oncol; 2006 Dec; 4(12):908-10. PubMed ID: 17235275
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood donor screening for parvovirus B19 in Germany and Austria.
    Schmidt M; Themann A; Drexler C; Bayer M; Lanzer G; Menichetti E; Lechner S; Wessin D; Prokoph B; Allain JP; Seifried E; Hourfar MK
    Transfusion; 2007 Oct; 47(10):1775-82. PubMed ID: 17714425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study.
    Park JB; Kim DJ; Woo SY; Choi GS; Chun JM; Jung GO; Kwon CH; Kim SJ; Joh JW; Lee SK
    Transpl Int; 2009 Apr; 22(4):455-62. PubMed ID: 19144091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative study to establish a replacement World Health Organization International Standard for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.
    Baylis SA; Chudy M; Blümel J; Pisani G; Candotti D; José M; Heath AB
    Vox Sang; 2010 Apr; 98(3 Pt 2):441-6. PubMed ID: 20003130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent infection by human parvovirus B19 in qualified blood donors.
    Matsukura H; Shibata S; Tani Y; Shibata H; Furuta RA
    Transfusion; 2008 May; 48(5):1036-7. PubMed ID: 18454740
    [No Abstract]   [Full Text] [Related]  

  • 17. Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman.
    Bonvicini F; Marinacci G; Pajno MC; Gallinella G; Musiani M; Zerbini M
    Clin Infect Dis; 2008 Aug; 47(3):385-7. PubMed ID: 18558883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens.
    Bonvicini F; Manaresi E; Gallinella G; Gentilomi GA; Musiani M; Zerbini M
    BJOG; 2009 May; 116(6):813-7. PubMed ID: 19432570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PNA-based probe for quantitative chemiluminescent in situ hybridisation imaging of cellular parvovirus B19 replication kinetics.
    Bonvicini F; Mirasoli M; Gallinella G; Zerbini M; Musiani M; Roda A
    Analyst; 2007 Jun; 132(6):519-23. PubMed ID: 17525808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower Incidence of Parvovirus-B19 Infections in Dutch Blood Donors during SARS-CoV-2 Pandemic.
    Molenaar-de Backer MW; Hogema BM; Koppelman MH; van de Laar TJ; Slot E; Zaaijer HL
    Microbiol Spectr; 2021 Oct; 9(2):e0025321. PubMed ID: 34523999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.